Lazzat Kassayeva

Dr. Lazzat Kassayeva


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 February 2026 in Pathogens
Verified
Journal Article
Open access
PDF file
AUAigul Maratovna Utegenova
Aigul Maratovna Utegenova
LKLazzat Kassayeva
Lazzat Kassayeva
BTBayan Turdalina
Bayan Turdalina
ABAliya Baiduissenova
Aliya Baiduissenova
Ayaz YktiyarovAyaz Yktiyarov
Ayaz Yktiyarov
ESEvgeni Sokurenko
Evgeni Sokurenko
Latent tuberculosis infection (LTBI) represents a major global health concern as it constitutes the principal reservoir for future tuberculosis (TB) disease. Its identification is particularly important in Bacille Calmette–Guérin (BCG)-vaccinated populations, where cross-reactivity of purified protein derivative limits the specificity of the tuberculin skin test and hampers targeted preventive therapy. Early Mycobacterium tuberculosis antigens encoded within the RD1 region, especially ESAT-6, CFP-10 and TB7.7, have enabled the development of antigen-specific interferon-gamma release assays (IGRAs) and recombinant skin tests with improved BCG-independent specificity. This narrative review integrates and critically appraises current evidence on the immunobiological properties of early and latency-associated antigens, the cellular mechanisms underlying T-cell-dependent immune reactivity, and the diagnostic performance of IGRAs and ESAT-6/CFP-10-based skin tests, rather than merely summarizing individual studies. Although these platforms rely on different assay principles (in vitro cytokine release versus in vivo delayed-type hypersensitivity), both measure antigen-specific T-cell memory and do not define the biological stage of infection or reliably distinguish latent from incipient or active TB. Across most adult populations, IGRAs demonstrate high specificity and acceptable sensitivity, whereas reduced sensitivity and higher rates of indeterminate results are observed in young children and immunocompromised individuals. ESAT-6/CFP-10-based skin tests show diagnostic accuracy comparable to IGRAs and may offer operational advantages in resource-limited settings. Latency-associated antigens and host biomarkers such as IP-10, together with multi-analyte immune signatures, represent promising avenues for improving diagnostic sensitivity and prognostic stratification but currently lack sufficient validation for routine clinical use. Overall, RD1-encoded antigens remain central to LTBI immunodiagnosis, while future research should focus on developing stage-resolving and prognostic biomarkers, optimized antigen panels, and standardized interpretive frameworks.

31 October 2022 in Наука и здравоохранение
Verified
Journal Article
Open access
LKLazzat Kassayeva
Lazzat Kassayeva
СССакыбаева С.а.
Сакыбаева С.а.
ЮШЮлдашева Ш.м.
Юлдашева Ш.м.
НКНасырова К.б.
Насырова К.б.
ДАДуйсенов А.ж.
Дуйсенов А.ж.
МГМуздыбаева Г.а.
Муздыбаева Г.а.
В структуре заболеваемости туберкулезом особую остроту приобретает проблема беременности у больных туберкулезом женщин. Безусловно, это связано с гормональными изменениями во время беременности, а наличие ВИЧ инфекции только усугубляет течение и исход, как туберкулеза, так и беременности. На сегодняшний день проблема коинфекции туберкулез/ВИЧ у беременных женщин остается до конца не изученной. Туберкулез (ТБ) является одной из самых распространенных оппортунистических инфекций у ВИЧ-инфицированных пациентов, особенно в регионах с его высокой распространенностью. Наихудший прогноз имеют беременные женщины с ко-инфекцией, при этом основными факторами, влияющими на исход и прогноз беременности, являются тяжесть и распространенность ТБ, наличие его внелегочных локализаций, плохая приверженность к лечению, а также срок беременности при выявлении ТБ. Эти факторы влияют и на частоту таких акушерских осложнений, как выкидыши, преждевременные роды, низкая масса тела новорожденного. Поздняя диагностика ТБ является независимым фактором, который увеличивает частоту акушерской патологии почти в 4 раза, а риск преждевременных родов - в 9 раз. Нами представлен клинический случай беременной женщины с коинфекцией (ТБ/ВИЧ). В Республике Казахстан данный клинический случай является единичным. Данным клиническим случаем мы показываем диагностику, течение и исход лечения туберкулеза у беременной женщины с коинфекцией, а также эффективность применения индивидуального режима лечения (ИРЛ). n the structure of the incidence of tuberculosis, the problem of pregnancy in women with tuberculosis becomes particularly acute. This is due to hormonal changes during pregnancy, and the presence of HIV infection worsens the course and outcome of both tuberculosis and pregnancy. The problem of tuberculosis/HIV co-infection in pregnant women remains not fully understood. Tuberculosis (TB) is one of the most common opportunistic infections in HIV-infected patients, especially in regions with its high prevalence. Pregnant women with co-infection have the worst prognosis, while the main factors affecting the outcome and prognosis of pregnancy are the severity and prevalence of TB, the presence of its extrapulmonary localizations, poor adherence to treatment, as well as the duration of pregnancy when TB is detected. These factors also affect the frequency of obstetric complications such as miscarriages, premature birth, and low newborn body weight. Late diagnosis of TB is an independent factor that increases the frequency of obstetric pathology by almost 4 times, and the risk of premature birth by 9 times. We present a clinical case of a pregnant woman with coinfection (TB/HIV). In the Republic of Kazakhstan, this clinical case is an isolated one. With this clinical case, we show the diagnosis, course and outcome of tuberculosis treatment in a pregnant woman with coinfection, as well as the effectiveness of the individual treatment regimen (ITR). Туберкулезбен сырқаттанушылық құрылымында туберкулезбен ауыратын әйелдерде жүктілік проблемасы ерекше айқындыққа тән. Әрине, бұл жүктілік кезіндегі гормоналды өзгерістерге байланысты, ал АИТВ-инфекциясының болуы туберкулездің де, жүктіліктің де ағымын және нәтижесін күшейтеді. Бүгінгі күні жүкті әйелдерде коинфекция туберкулез/АИТВ мәселесі толық зерттелмеген. Туберкулез (ТБ) АИТВ жұқтырған пациенттерде, әсіресе оның таралуы жоғары өңірлерде ең көп таралған оппортунистік инфекциялардың бірі болып табылады. Ең нашар болжамға ко-инфекциясы бар жүкті әйелдер ие, бұл ретте жүктіліктің нәтижесі мен болжамына әсер ететін негізгі факторлар: ТБ ауырлығы мен таралуы, оның өкпеден тыс орналасуының болуы, емдеуге нашар бейілділігі, сондай-ақ ТБ анықталған кездегі жүктілік мерзімі болып табылады. Бұл факторлар түсік түсіру, мерзімінен бұрын босану, жаңа туған нәрестенің дене салмағының төмендігі сияқты акушерлік асқынулардың жиілігіне де әсер етеді....